ALS (Amyotrophic Lateral Sclerosis)
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease affecting motor neurons—the nerve cells controlling voluntary muscle movement. As motor neurons die, muscles weaken and waste away, eventually affecting speaking, swallowing, and breathing.
Prevalence
Approximately 30,000 Americans have ALS at any given time, with about 5,000 new diagnoses annually. Life expectancy is typically 2-5 years from diagnosis, though some patients live longer.
Who It Affects
Most commonly diagnosed between ages 40-70, with an average age of 55. Slightly more common in men. About 5-10% of cases are familial (inherited); the rest are sporadic with unknown cause.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Riluzole
First FDA-approved ALS drug; modestly slows progression.
Limitations: Extends survival by only 2-3 months on average. Does not reverse disease.
Edaravone
Antioxidant that may slow functional decline in some patients.
Limitations: Modest benefit in selected patients. Requires IV infusion. Expensive.
Tofersen (for SOD1 mutation)
Antisense therapy for patients with SOD1 genetic mutation.
Limitations: Only for specific genetic form of ALS (~2% of cases).
Supportive Care
Respiratory support, feeding tubes, physical therapy, communication devices.
Limitations: Essential for quality of life but does not stop disease progression.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for ALS is an area of active but early research. Scientists are exploring whether stem cells may help support motor neurons, modulate neuroinflammation, or provide neurotrophic support. Several clinical trials are ongoing worldwide.
Potential Benefits Being Studied:
- Being studied for potential neurotrophic (nerve-supporting) effects
- Research exploring slowing of disease progression
- May help modulate neuroinflammation (under investigation)
- Multiple clinical trials ongoing globally
- Some studies showing potential to stabilize function temporarily
- Does not replace standard ALS care
Biologics Used:
Mesenchymal stem cells in clinical trials
Neural stem cells being studied
Exosomes with neurotrophic factors under investigation
Frequently Asked Questions
Can stem cells cure ALS?
No. There is currently no cure for ALS. While stem cell research shows some promise in clinical trials, no regenerative therapy has been proven to cure or reverse ALS. Research is ongoing.
Should I try experimental treatments?
This is a deeply personal decision. Consider participating in legitimate clinical trials through ALS centers. Be cautious of expensive treatments with unproven claims. Discuss options with your ALS care team.
What results have been seen in trials?
Some trials have shown temporary stabilization or slowed decline in some patients. Results are variable and no definitive breakthrough has occurred. Research continues with multiple approaches.
Ready to Explore Your Options?
Schedule a free consultation to discuss als (amyotrophic lateral sclerosis) and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for ALS are highly investigational and not FDA-approved. ALS is a serious disease requiring specialized care. Be cautious of unproven treatments with exaggerated claims. Consult with an ALS specialist.